1. Home
  2. WVE vs RXT Comparison

WVE vs RXT Comparison

Compare WVE & RXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.04

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Rackspace Technology Inc.

RXT

Rackspace Technology Inc.

HOLD

Current Price

$4.97

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
RXT
Founded
2012
1998
Country
Singapore
United States
Employees
317
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
WVE
RXT
Price
$6.04
$4.97
Analyst Decision
Strong Buy
Hold
Analyst Count
16
6
Target Price
$29.81
$1.71
AVG Volume (30 Days)
2.2M
12.7M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
75.13
EPS
N/A
0.03
Revenue
$3,704,000.00
$2,685,700,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$85.67
$1.35
P/E Ratio
N/A
$161.67
Revenue Growth
149.43
N/A
52 Week Low
$5.02
$0.39
52 Week High
$21.73
$8.60

Technical Indicators

Market Signals
Indicator
WVE
RXT
Relative Strength Index (RSI) 53.05 51.57
Support Level $5.49 $3.78
Resistance Level $6.21 $6.15
Average True Range (ATR) 0.25 0.36
MACD 0.03 0.13
Stochastic Oscillator 83.54 77.71

Price Performance

Historical Comparison
WVE
RXT

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi-cloud technology services company. It designs, builds, and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services, Data, Colocation, Cloud, Managed Hosting, Professional Services, and Security and Compliance. It has two reportable segments: Private Cloud and Public Cloud. Maximum revenue is generated from the Public Cloud segment, which offers cloud solutions through managed services, elastic engineering, and professional services offerings for customer environments hosted on the AWS, Microsoft Azure, and Google Cloud public cloud platforms. Geographically, the company derives its key revenue from the U.S.

Share on Social Networks: